Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Fortis Healthcare Launches Comprehensive Cancer Care Institute in the Tricity


News provided by

Fortis Healthcare Ltd

25 Jul, 2014, 17:13 IST

Share this article

Share toX

Share this article

Share toX

MOHALI, India, July 25, 2014 /PRNewswire/ --

State-of-the-art Facility Brings the Latest Medical, Surgical and Radiation Oncology Services in North India  

In an effort to significantly elevate the delivery of world-class cancer care services in the region, Fortis Healthcare Limited today launched the 'Fortis Cancer Institute' at Mohali, ushering in the latest available modalities in medical, surgical and radiation oncology. The institute is by far one of the most comprehensive cancer treatment centres in Punjab.

In his inaugural address, Sardar Parkash Singh Badal, Honourable Chief Minister of Punjab said, "Fortis has been a long standing partner to the state, bringing in much needed high quality healthcare services. In the recent years, the incidence of cancer has been growing steadily, causing increasing medical burden on the people in the region. Therefore, it is noteworthy that on my request and persuasion, Fortis has built this much needed state-of-the-art facility that specialises in the early detection and treatment of cancer. I applaud their efforts and wish them all success in this endeavour."

Mr. Malvinder Mohan Singh and Mr. Shivinder Mohan Singh, Executive Chairman and Executive Vice-Chairman, Fortis Healthcare Limited, said, "We have our roots in Punjab, having set up our first hospital in Mohali in 2001. Our intent has always been to bring the highest quality healthcare to the doorstep of people in the state. Today, we consider it our privilege to launch a dedicated facility for cancer treatment that will provide relief and hope to thousands of people in the region afflicted with this dreaded disease. We remain committed to improving the quality of healthcare in the region and to expand our footprint further so more people can benefit from it."

Cancer continues to be among the leading causes of mortality worldwide. The number of people suffering from cancer is expected to increase from 14 million in 2012 to 22 million within the next two decades. This worrisome trend is even more alarming in Punjab, where the incidence of cancer is as high as 90 per 1 lakh population, much higher than the national average. Access to quality cancer care also remains a challenge. In the last five years alone, more than 34,430 individuals have succumbed to the disease, of which 14,682 were in the Malwa region alone.

The Fortis Cancer Institute is well equipped to detect quantify and treat the earliest and most minute of lesions through targeted high-precision radiation therapy. It has the region's most advanced Image Guided Radiation Therapy (IGRT) unit that uses motion based technology to 'map' the tumours, while simultaneously delivering precise doses of radiation therapy to the specific diseased area. This accuracy in treatment minimises radiation exposure to co-located healthy tissues and organs, preventing collateral damage. With the capability to deliver radiation up to sub-millimetre targets, IGRT is an excellent therapeutic tool. It is especially important in tissues that move due to breathing such as lung tumours and is of particular importance in treating head and neck tumours and in prostate carcinomas. Early detection and treatment of cancer is key to improving outcomes, the prospects of healing and the return to normal life. 

Other state-of-the-art technologies deployed at the institute include IMRT - Intensity Modulated Radiation Therapy, ART - Adaptive Radiation Therapy, VMAT - Volumetric Modulated Arc Therapy, SRS - Stereotactic Radio Surgery, SRT - Stereotactic Radiation Therapy and BRACHYTHERAPY - 18 channel HDR system for interstitial and intra-cavitary brachytherapy. For early and precise detection of cancer, the Fortis Cancer Institute is equipped with the most advanced PET-CT, an imaging tool that combines two scan techniques in one. There is also provision for MRI/PET-CT fusion-based radiation planning technology.

Fortis Mohali has been regularly conducting several programs to create awareness and help in early prevention and diagnosis of cancer. Some of the noteworthy initiatives include: Cancer screening camps with educational institutions, NGOs, senior citizens associations, Rotary Club, corporates, Saarthak, a cancer support group and an informal platform to engage with clinicians for patients and their families to overcome the battle against cancer and learn from experiences of other patients, awareness drives in slums and breast and cervical cancer screenings for women.

Fortis Cancer Institute follows the Tumour Board review, a plan-based approach to treatment, where doctors from different clinical specialties discuss and review the medical condition and treatment modalities for a patient. The board comprises of a medical, surgical and radiation oncologist to ensure that a holistic multidisciplinary approach to treatment is followed.

The comprehensive multidisciplinary expertise available at the Fortis Cancer Institute encompasses a variety of sub-specialties ranging from gynae-onco, uro-onco, paediatric-onco, ortho-onco, haemato-onco, neuro-onco, breast-onco, endocrine, liver, head and neck, oral, ocular cancer, pain & palliative services and also includes a stoma clinic, making it a one stop treatment centre for all forms of cancer. Specialised cancer clinics have been constituted so that patients can benefit from the experience and specialization of various surgeons.

The Fortis Cancer Institute harnesses the best clinical talent to treat individualised health conditions in cancer care. A team of acclaimed medical professionals has been judiciously put together, that includes:

- Dr Rajeev Bedi, DM Ex-AIIMS, as Director and Head of Medical Oncology. Dr Bedi is the recipient of Gold Medal and Geeta Mittal Award for Best Cancer Researcher of the year 2002.

- Dr Jai Dev Wig, Director & Head of General Surgery, also Head of the Surgical Oncology team. Dr Wig has over 40 years of rich experience, including holding the post of Professor & Head of General Surgery at the prestigious PGIMER, Chandigarh.

- The team of oncology surgeons includes: Dr Rajeev Kapoor (trained in colorectal surgery from Australia) with over 25 years of experience. He is also the former Head of Surgery - CMC Ludhiana; Dr Atul Sharma Joshi, with over 14 years of experience and a postgraduate in General Surgery from PGIMER Chandigarh; and Dr Rudra Pratap Doley, MS - General Surgery and MCh - GI Surgery from PGIMER Chandigarh.

- Dr Ritu Aggarwal, MBBS from IGMC-Shimla with a post-graduation in radiation oncology. She has eight years of experience in radiation oncology. Dr Ritu has received special training in advanced techniques of radiation oncology from West Middlesex University Hospital, UK.

About Fortis Mohali 

Fortis Hospital Mohali is a 427-bed, JCI and NABH-certified, multi-specialty care hospital. The hospital commenced operations in 2001, and is considered as one of the highly recognised cardiac centres of India. Located in the heart of Punjab over 8.22 acres, the tertiary care hospital has a comprehensive team of clinicians delivering world-class patient care, supported by advanced technology.

Fortis Oncology Centres of Excellence (CoE)  

Cancer continues to be among the leading causes of mortality worldwide. Fortis' comprehensive centres of excellence for oncology provide end-to-end cancer care across medical, radiation and surgical oncology, ranging from diagnostics, treatment and rehabilitation, integrated cutting-edge medical technology and internationally acclaimed clinical expertise to treat tumours and cancer. Fortis oncology centres across the network include: the company's flagship Fortis Memorial Research Institute (FMRI), Gurgaon, Fortis Mulund, Mumbai, Fortis Ludhiana, Punjab, the newly launched Institute in Mohali, Punjab and the proposed Centre for Oncology at BG Road, Bangalore, to address the growing need for specialised and quality medical care to treat cancer.

About Fortis Healthcare Limited 

Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Singapore, Dubai, Mauritius and Sri Lanka with 66 healthcare facilities (including projects under development), over 10,000 potential beds and approx. 280 diagnostic centres. In a global study of the 30 most technologically advanced hospitals in the world, its flagship, the Fortis Memorial Research Institute (FMRI) was ranked No.2 by topmastersinhealthcare.com, and placed ahead of many other outstanding medical institutions in the world.

Primary Media Contact: Nibha Bhandari, +91-9811065557, [email protected]

Secondary Media Contact: Raghu Kochar, +91-9811617256, [email protected]                  

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.